Spondylodiscitis relevant tissue concentrations of cefuroxime - a large animal microdialysis study
European Spine Journal · 2025-06 · 34 (6) · 2145-2151
DOI: 10.1007/s00586-025-08718-y ↗Kurz gefasst
Fachartikel in der Zeitschrift European Spine Journal, online erschienen am 14.02.2025. Verfasst von Jake Paul Lawrence Bastian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark. Hauptthemen laut MEDLINE: Cefuroxime, Anti-Bacterial Agents, Discitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aarhus Universitet.
Abstract (Originalsprache)
Purpose
Spondylodiscitis is a serious condition requiring prolonged antibiotic therapy. Relevant pharmacokinetic tissue understanding of antibiotics in a spondylodiscitis setting is limited. The study aimed to investigate cefuroxime concentrations in the L4/L5 intervertebral disc, lumbar bone, paravertebral muscle and subcutaneous tissue using microdialysis.
Methods
Eight pigs received 1,500 mg of cefuroxime by intravenous bolus infusion over 10 min. Prior to cefuroxime administration, microdialysis catheters were placed in the L4/L5 intervertebral disc, lumbar bone, paravertebral muscle and adjacent subcutaneous tissue for sampling across an 8-h dosing interval. Plasma samples were obtained for reference. Based on prior time-kill modelling for cefuroxime, 40% of the dosing interval with concentrations above the minimum inhibitory concentration (40% T > MIC) for Staphylococcus aureus was chosen as the primary endpoint.
Results
The 40% T > MIC target exposure was surpassed in all investigated compartments in 5/8 pigs at the lowest MIC-target of 1 $$\:\mu\:$$ g/mL. None of the pigs achieved the 40% T > MIC at the clinical breakpoint MIC for S. aureus of 4 $$\:\mu\:$$ g/mL. Mean %T > MIC was comparable across the spondylodiscitis relevant tissues at MICs of 1 (range: 43–60%), 2 (range: 30–38%) $$\:,$$ and 4 $$\:\mu\:$$ g/mL (range: 16–26%).
Conclusion
Short-infused cefuroxime dosing standards may under-treat S. aureus spondylodiscitis, increasing the risk of inadequate bacterial killing and resistance development. Given the severity of spondylodiscitis, alternate clinical dosing strategies for cefuroxime may be necessary, such as shorter dosing intervals or prolonged/continuous infusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
- Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus N, Denmark.
- Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus N, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark. matsbue@clin.au.dk.
- Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus N, Denmark. matsbue@clin.au.dk.
- Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus N, Denmark. matsbue@clin.au.dk.
ORCID-Profile: Mats Bue
Förderung
- Aarhus Universitet
Zitieren
APA
Bastian, J. P. L., Hvistendahl, M. A., Høy, K., Stilling, M., & Bue, M. (2025). Spondylodiscitis relevant tissue concentrations of cefuroxime - a large animal microdialysis study. European Spine Journal, 34(6), 2145-2151. https://doi.org/10.1007/s00586-025-08718-y
Vancouver
Bastian JPL, Hvistendahl MA, Høy K, Stilling M, Bue M. Spondylodiscitis relevant tissue concentrations of cefuroxime - a large animal microdialysis study. European Spine Journal. 2025;34(6):2145-2151. doi:10.1007/s00586-025-08718-y
BibTeX
@article{Bastian2025,
author = {Bastian, Jake Paul Lawrence and Hvistendahl, Magnus A and Høy, Kristian and Stilling, Maiken and Bue, Mats},
title = {Spondylodiscitis relevant tissue concentrations of cefuroxime - a large animal microdialysis study},
journal = {European Spine Journal},
year = {2025},
volume = {34},
number = {6},
pages = {2145--2151},
doi = {10.1007/s00586-025-08718-y}
}
EUVIMED